In the present meta-analysis, though omitting the two studies [4, 7] that focused on pediatric patients did not alter the results or reduce the heterogeneity (S4 Table), the effect of increasing age on clinical outcome of CBF-AML with KIT mutations could not be technically analyzed. Here, CEBPZ is linked to acute myeloid leukemia.